Search Reports:

Enter company name or symbol or keyword from report title or report description. You can also use our advanced search option to further filter your results.

Accuracy of Opinions

984 (79%) - Correct
255 (21%) - Incorrect

Explanation

Recent News on Covered Stocks

Registration

On successful registration you will get a confirmation email with your username , password and a default credit of $10 (What's this). This will be adjusted against all future purchases.

First Name *

Last Name *

Email Id *

Subscription Type * Explanation  
Password *

 
Confirm Password *

 
Contact Number *

 
Address *

 
City *

 
State *

 
Zip Code *

 
Country *

 
Age Group  
Timeline For Investment Objectives  
Size Of Typical Investment  
Preferred Type Of Healthcare Stocks  
   Re-generate
Security Code *

I have read the Terms and Conditions & Disclosure Agreement
     
   
Notes: * All Fields are Mandatory  

Sample Report:

VRTX's HCV drug Telaprevir received FDA approval on May 23, 2011. New BioMedicine had issued a report on this event on May 3, 2011. To read more about the drug, the disease, the market, the competition, etc. access it at the link below.
 

Basket Reports:

Free Basket Reports

Specific theme-based reports at a value price
View Package

©Copyright 2012 New Bio Medicine, LLC. All Right Reserved.